US Patent 11365394 Enhanced immune effector cells and use thereof
Patent 11365394 was granted and assigned to Fate Therapeutics on June, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11365394 Enhanced immune effector cells and use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.